Quinazoline derivatives exert an inhibitory effect on osteosarcoma growth by inhibiting the phosphorylation and signaling pathways of FGFR4 (Querolle et al., 2015; Nandi and Bagchi, 2016; Voskoboynik et al., 2016). Here, FGFR4 is linked to osteosarcoma.